1. Home
  2. ALCO vs ACIU Comparison

ALCO vs ACIU Comparison

Compare ALCO & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alico Inc.

ALCO

Alico Inc.

SELL

Current Price

$38.27

Market Cap

297.3M

Sector

N/A

ML Signal

SELL

Logo AC Immune SA

ACIU

AC Immune SA

SELL

Current Price

$2.40

Market Cap

247.6M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ALCO
ACIU
Founded
1960
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.3M
247.6M
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
ALCO
ACIU
Price
$38.27
$2.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $45.00
$8.57
AVG Volume (30 Days)
18.5K
★ 194.2K
Earning Date
11-23-2026
11-03-2026
Dividend Yield
★ 0.52%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.32
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$422.39
Revenue Next Year
N/A
$377.85
P/E Ratio
$28.98
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$31.32
$2.10
52 Week High
$45.01
$4.00

Technical Indicators

Market Signals
Indicator
ALCO
ACIU
Relative Strength Index (RSI) 40.56 37.63
Support Level $37.46 $2.13
Resistance Level $42.05 $2.41
Average True Range (ATR) 0.62 0.14
MACD -0.01 -0.03
Stochastic Oscillator 12.57 8.49

Price Performance

Historical Comparison
ALCO
ACIU

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that mainly focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers the majority of the revenue as the firm's primary operating business unit.

About ACIU AC Immune SA

AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: